ArticleProceedings of the National Academy of Sciences of the United States of America2022

Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders.

Valentina Damato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.